,

Retatrutide, 10mg

165,00 $

Deploy the definitive triple-hormone metabolic breakthrough. Experience uncompromised weight reduction, fully eliminate intense food cravings, and switch your basal metabolic furnace into overdrive with our elite, ultra-pure GIP/GLP-1/Glucagon triple receptor agonist.

Availability: 100 in stock

- +

Product Category

Triple Hormone Receptor Agonists (GIP/GLP-1/GCG) & Next-Gen Weight Management Peptides

Action on the Human Body

Retatrutide is a synthetic, single peptide chain acylated with a C18 fatty diacid moiety, engineered to function as a potent triple agonist at the Glucose-Dependent Insulinotropic Polypeptide (GIP), Glucagon-Like Peptide-1 (GLP-1), and Glucagon (GCG) receptors. By engaging this triad, Retatrutide rewires energy balance structures: GIP receptor binding stabilizes glycemic fluctuations and manages nausea thresholds; GLP-1 receptor activation slows gastric emptying and triggers central satiety networks in the hindbrain; and Glucagon receptor engagement upregulates energy expenditure by stimulating thermogenesis directly within brown adipose tissue, while simultaneously clearing lipid stores out of hepatic layers. This combined action achieves exceptional fat mass reduction and extensive metabolic correction.

What to Expect if Consumed

Users experience complete freedom from food noise, substantial fat tissue reduction, increased daily caloric burning capacity, and optimized metabolic parameters without typical energy crashes.

Possible Therapy Combinations

Pairs perfectly with 5-Amino-1MQ to drive an intense metabolic and cell-slimming cycle, or combined with BPC-157 to manage gastric transition paths and protect mucosal lining integrity.

Molecular Formula & Chemical Composition

Sequence: 39-amino acid acylated peptide backbone. Molecular Formula: C221H342N46O68. Purity: >99% Pure Lyophilized Form via strict HPLC analytical validation.

WARNING: This peptide compound must be handled and utilized exclusively under very high, correct professional and qualified medical supervision. Misuse can lead to unintended biological variations.

Scientific References

1. Jastreboff, A. M., et al. (2023). ‘Triple-hormone-receptor agonist retatrutide for obesity – A phase 2 trial.’ New England Journal of Medicine.
2. Coskun, T., et al. (2026). ‘Retatrutide (LY3437943), a novel triple GIP, GLP-1, and glucagon receptor agonist: Biochemical design and metabolic mechanisms.’ Cell Metabolism.

Why choose our Retatrutide, 10mg?

  • Guaranteed 99%+ Purity: Synthesized specifically for rigorous laboratory and analytical research.
  • Strict Quality Control: Verified via HPLC and MS testing to ensure precise molecular concentration.
  • Secure & Stable Shipping: Packaged carefully to maintain compound stability during transit.

Note: This product is sold exclusively for laboratory research purposes only. It is not intended for human or veterinary use.

Certificate of Analysis Available

This product has been verified by independent third-party testing. Download the full COA below.

Purity: 99.78
Mass/Content: 10
Report Date: 04 Feb 2026
🔬 Testing Methodology: All batches are verified using dual-wavelength High-Performance Liquid Chromatography (HPLC) paired with Electro-Spray Ionization Mass Spectrometry (ESI-MS) by ISO-certified independent laboratories.
Shopping Cart
Scroll to Top